---
layout: post
title: "Prescription Drug User Fee Act of 2017; Electronic Submissions and Data Standards; Public Meeting; Request for Comments"
date: 2026-02-05 19:08:25 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-02163
original_published: 2020-02-05 00:00:00 +0000
significance: 8.00
---

# Prescription Drug User Fee Act of 2017; Electronic Submissions and Data Standards; Public Meeting; Request for Comments

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** February 05, 2020 00:00 UTC
**Document Number:** 2020-02163

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the following public meeting entitled "Prescription Drug User Fee Act of 2017; Electronic Submissions and Data Standards." The purpose of the public meeting and the request for comments is to fulfill FDA's commitment to seek stakeholder input related to data standards and the electronic submission system's past performance, future targets, emerging industry needs, and technology initiatives. FDA will use the information from the public meeting as well as from comments submitted to the docket to inform data standards initiatives, FDA Information Technology (IT) Strategic Plan, and electronic submissions gateway target timeframes.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/02/05/2020-02163/prescription-drug-user-fee-act-of-2017-electronic-submissions-and-data-standards-public-meeting)
- API: https://www.federalregister.gov/api/v1/documents/2020-02163

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
